pharmaceutical and related health care products

McKesson has been awarded a contract by the State of Texas (Contract ID: HHSTX-7-0000411221) effective August 4, 2026, to supply pharmaceutical and related healthcare products. The contract encompasses the provision of specialized allergenic extracts and advanced pharmaceutical preparations classified under miscellaneous drugs and pharmaceuticals. The product scope includes multiple allergenic extract formulations—specifically alfalfa allergenic extract, alder allergenic extract, and rabbit epithelium allergenic extract—as well as two therapeutic pharmaceutical products: fecal microbiota transplant preparation and vestronidase alfa.

The contract deliverables fall within the United Nations Standard Products and Services Code (UNSPSC) categories for allergenic extracts and specialized pharmaceutical preparations, with classification under the National Institute of Governmental Purchasing (NIGP) code for miscellaneous drugs and pharmaceuticals not otherwise classified. Specific contract valuation details, including annual value, total contract amount, and cumulative value, were not disclosed in the award documentation. Similarly, detailed information regarding the period of performance, specific geographic location of performance, and the procuring agency organization within Texas were not provided in the available contract information.